Literature DB >> 3067744

The 12-hour control of intraocular pressure on carteolol 2% twice daily.

G R Duff1, R G Newcombe.   

Abstract

In a 15-week double-blind, placebo-controlled, crossover study both carteolol 2% and timolol 0.5% produced a significant reduction in intraocular pressure. Twelve hours after administration the reduction in pressure on carteolol was significantly less than that obtained on timolol.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3067744      PMCID： PMC1041615          DOI： 10.1136/bjo.72.12.890

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


  3 in total

1.  [Effects of beta-blocking agent carteolol on healthy volunteers and glaucoma patients (author's transl)].

Authors:  C Negishi; S Ueda; A Kanai; A Nakajima; M Funahashi; Y Kitazawa; S Komemushi
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1981-01

2.  [Ocular hypotensive effects of carteolol hydrochloride in primary open-angle glaucoma and ocular hypertensive patients. A double-masked cross-over study for the determination of concentrations optimal for the clinical use (author's transl)].

Authors:  Y Kitazawa; I Azuma; M Takase; S Komemushi
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1981

3.  A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure.

Authors:  G R Duff; P A Graham
Journal:  Br J Ophthalmol       Date:  1988-01       Impact factor: 4.638
  3 in total
  4 in total

1.  Short-term comparative study of topical 2% carteolol with and without benzalkonium chloride in healthy volunteers.

Authors:  C Baudouin; C de Lunardo
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

Review 2.  Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension.

Authors:  P Chrisp; E M Sorkin
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

Review 3.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

4.  A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.

Authors:  W C Stewart; M B Shields; R C Allen; R A Lewis; J S Cohen; H D Hoskins; J N Hetherington; R L Bahr; J E Noblin; J T Delehanty
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.